Results 41 to 50 of about 3,258,123 (297)

Using the canine microbiome to bridge translation of cancer immunotherapy from pre-clinical murine models to human clinical trials

Frontiers in Immunology, 2022
The microbiome has clearly been established as a cutting-edge field in tumor immunology and immunotherapy. Growing evidence supports the role of the microbiome in immune surveillance, self-tolerance, and response to immune checkpoint inhibitors such as ...
Kara T. Kleber, Khurshid R. Iranpur, Lauren M. Perry, Sylvia M. Cruz, Aryana M. Razmara, William T. N. Culp, Michael S. Kent, Jonathan A. Eisen, Robert B. Rebhun, Robert J. Canter   +9 more
doaj   +1 more source

Editorial: Rising stars in radiation oncology 2022 [PDF]

, 2023
As patient care has matured and become increasingly complex, the fundamental skill set for the modern radiation oncologist has evolved as well. The initial generation of radiation oncologists trained in the United States and North America were taught by ...
FitzGerald, Thomas J
core   +1 more source

Supplementary Data from Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs

, 2022
Supplementary Data from Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing ...
Brian K. Flesner (15028172), Feng Wang (15092326), Scott Harris (15092329), James H. Doroshow (13270697), Shan Li (15092323), Apurva K. Srivastava (15092344), Jeevan P. Govindharajulu (15092335), Barbara Mroczkowski (15092356), Tsui-Fen Chou (15092347), Amy K. LeBlanc (15092314), Francesca Tomaino (15092341), Joseph M. Covey (15092353), Soumya Jaganathan (15092338), Gordon M. Stott (15092350), Christina N. Mazcko (15092317), Timothy M. Fan (15092320), Jeffrey N. Bryan (15010845), Jesse D. Vargas (15092332), David M. Vail (15028175)   +18 more
core   +1 more source

Retrospective study of melanocytic neoplasms in dogs and cats

Brazilian Journal of Veterinary Pathology, 2010
Melanoma is one of the most lethal skin neoplasms among dogs and cats, and its incidence is increasing worldwide in the last years. The relation between the study of tumor biology and epidemiologic data from melanocytic tumors (melanomas and ...
Tarso F. Teixeira, Tereza C. da Silva, Bruno Cogliati, Márcia K. Nagamine, Maria L. Z. Dagli   +4 more
doaj   +1 more source

Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma

Frontiers in Oncology, 2021
The importance of inflammation in the pathogenesis of cancer was first proposed by Rudolph Virchow over 150 years ago, and our understanding of its significance has grown over decades of biomedical research.
Walaa Hamed Shaker Nasry, Chelsea K. Martin   +1 more
doaj   +1 more source

Understanding the role of comparative clinical studies in the development of oncology biosimilars [PDF]

, 2020
Biosimilars have the potential to broaden patient access to biologics and provide cost savings for health care systems. During the development of a biosimilar, data that directly compare the proposed biosimilar with the reference product are required ...
Rugo H. S., Bair A. H., Mainwaring P. N., Latymer M., Pegram M., Stebbing J., Curigliano G.   +6 more
core   +1 more source

MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects

Cells, 2021
Osteosarcoma (OS) is the most frequent primary malignant tumor of bone in humans and animals. Comparative oncology is a field of study that examines the cancer risk and tumor progression across the species.
Leonardo Leonardi, Katia Scotlandi, Ilaria Pettinari, Maria Serena Benassi, Ilaria Porcellato, Laura Pazzaglia   +5 more
doaj   +1 more source

Imatinib resistance mutation analysis: experience from a tertiary oncology center [PDF]

, 2015
Purpose: BCR-ABL kinase domain (KD) mutations account for 50-90% of the imatinib resistance observed in patients of CML-chronic phase. In CML-CP patients receiving imatinib first-line, mutation analysis is recommended in case of failure or suboptimal ...
Sirsath, Nagesh; Department of medical oncology, Kidwai memorial institute of oncology, Banglore, Lakshmaiah, Kuntejowdahalli; Department of medical oncology, Kidwai memorial institute of oncology, Banglore, Suresh Babu, Mallekavu; Department of medical oncology, Kidwai memorial institute of oncology, Banglore, Dasappa, Lokanatha; Department of medical oncology, Kidwai memorial institute of oncology, Banglore, Babu, Govind; Department of medical oncology, Kidwai memorial institute of oncology, Banglore, Martahalli, Suresh; Department of medical oncology, Kidwai memorial institute of oncology, Banglore   +5 more
core   +2 more sources

The Use of Oncept Melanoma Vaccine in Veterinary Patients: A Review of the Literature

Veterinary Sciences, 2022
The Oncept melanoma vaccine is xenogeneic DNA vaccine targeting tyrosinase. It is USDA approved for treatment of stage II to III canine oral melanoma and is also used off-label for melanomas arising in other locations and in other species.
MacKenzie A. Pellin
doaj   +1 more source

Psychosocial Care in Cancer: An overview of psychosocial programmes and national cancer plans of countries within the International Federation of Psycho-Oncology Societies

, 2012
We report data from representatives of national professional psycho-oncology societies on the integration of psychosocial care into national cancer programmes or cancer plans.
WATSON M., GRASSI, Luigi, FEDERATION OF PSYCHO ONCOLOGY SOCIETIES   +2 more
core   +1 more source